Resultados de búsqueda - Diletta Bianchini

Limitar resultados
  1. 1
    Immunotherapy-Induced Overlap Syndrome: Myositis, Myasthenia Gravis, and Myocarditis—A Case Series

    Immunotherapy-Induced Overlap Syndrome: Myositis, Myasthenia Gravis, and Myocarditis—A Case Series por Nikhil Aggarwal, Diletta Bianchini, Rosemeen Parkar, J. Turner

    Publicado 2024
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  2. 2
    Primary Cardiac Angiosarcoma: A Fatal Disease

    Primary Cardiac Angiosarcoma: A Fatal Disease por Lorenzo Antonuzzo, Virginia Rotella, Francesca Mazzoni, Laura Doni, Diletta Bianchini, Francesca Garbini, V. Maio, Francesco Di Costanzo

    Publicado 2009
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)

    Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100) por Yohann Loriot, Diletta Bianchini, E. Ileana, Shahneen Sandhu, Anna Patrikidou, Carmel Pezaro, Laurence Albigès, Gerhardt Attard, Karim Fizazi, Johann S. de Bono, Christophe Massard

    Publicado 2013
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use

    Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline... por David Lorente, Joaquı́n Mateo, Arnoud J. Templeton, Zafeiris Zafeiriou, Diletta Bianchini, Roberta Ferraldeschi, Amit Bahl, Liji Shen, Zhen Su, Oliver Sartor, Johann S. de Bono

    Publicado 2014
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    Visceral Disease in Castration-resistant Prostate Cancer

    Visceral Disease in Castration-resistant Prostate Cancer por Carmel Pezaro, Aurelius Omlin, David Lorente, Daniel Nava Rodrigues, Roberta Ferraldeschi, Diletta Bianchini, Deborah Mukherji, Ruth Riisnaes, Amelia Altavilla, Mateus Crespo, Nina Tunariu, Johann S. de Bono, Gerhardt Attard

    Publicado 2013
    Enlace del recurso
    Carta
    Agregar a favoritos
    Guardado en:
  6. 6
    Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts

    Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts por David Lorente, David Olmos, Joaquı́n Mateo, David Dolling, Diletta Bianchini, George Seed, Penelope Flohr, Mateus Crespo, I. Figueiredo, Susana Miranda, Howard I. Scher, Leon W.M.M. Terstappen, Johann S. de Bono

    Publicado 2018
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?

    Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance? por Janusz Mezynski, Carmel Pezaro, Diletta Bianchini, Andrea Zivi, Shahneen Sandhu, E. Thompson, John W. Hunt, Elizabeth Sheridan, Bindumalini Rao Baikady, Ajit Sarvadikar, Gal Maier, Alcuin Reid, Amy Mulick, David Olmos, Gerhardt Attard, Johann S. de Bono

    Publicado 2012
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer

    First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate can... por Diletta Bianchini, Aurelius Omlin, Carmel Pezaro, David Lorente, Roberta Ferraldeschi, Deborah Mukherji, Mateus Crespo, I. Figueiredo, Susana Miranda, Ruth Riisnaes, Andrea Zivi, Aby Buchbinder, Dana E. Rathkopf, Gerhardt Attard, Howard I. Scher, Johann S. de Bono, Daniel C. Danila

    Publicado 2013
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents

    Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents por Mateus Crespo, Guus van Dalum, Roberta Ferraldeschi, Zafeiris Zafeiriou, Spyridon Sideris, David Lorente, Diletta Bianchini, Daniel Nava Rodrigues, Ruth Riisnaes, Susana Miranda, I. Figueiredo, Penelope Flohr, Karolina Nowakowska, Johann S. de Bono, Leon W.M.M. Terstappen, Gerhardt Attard

    Publicado 2015
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer

    Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer por Pasquale Rescigno, David Lorente, Diletta Bianchini, Roberta Ferraldeschi, Michael Paul Kolinsky, Spyridon Sideris, Zafeiris Zafeiriou, Semini Sumanasuriya, Alan D. Smith, Niven Mehra, Anuradha Jayaram, Raquel Pérez-López, Joaquı́n Mateo, Chris Parker, David P. Dearnaley, Nina Tunariu, Alison Reid, Gerhardt Attard, Johann S. de Bono

    Publicado 2016
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  11. 11
    Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer

    Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer por David Lorente, David Olmos, Joaquı́n Mateo, Diletta Bianchini, George Seed, Martin Fleisher, Daniel C. Danila, Penny Flohr, Mateus Crespo, Ines Figueiredo, Susana Miranda, Kurt Baeten, Arturo Molina, Thian Kheoh, Robert McCormack, Leon W.M.M. Terstappen, Howard I. Scher, Johann S. de Bono

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  12. 12
    Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA)

    Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA) por Niven Mehra, David Dolling, Semini Sumanasuriya, Rossitza Christova, Lorna Pope, Suzanne Carreira, George Seed, Wei Yuan, Jane Goodall, Emma Hall, Penny Flohr, Gunther Boysen, Diletta Bianchini, Oliver Sartor, Mario A. Eisenberger, Karim Fizazi, Stéphane Oudard, Mustapha Chadjaa, Sandrine Macé, Johann S. de Bono

    Publicado 2018
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  13. 13
    Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study

    Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study por Raquel Pérez-López, Joaquı́n Mateo, Helen Mossop, Matthew Blackledge, David J. Collins, Mihaela Rata, Veronica A. Morgan, Alison Macdonald, Shahneen Sandhu, David Lorente, Pasquale Rescigno, Zafeiris Zafeiriou, Diletta Bianchini, Núria Porta, Emma Hall, Martin O. Leach, Johann S. de Bono, Dow‐Mu Koh, Nina Tunariu

    Publicado 2016
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  14. 14
    Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency

    Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency por Zafeiris Zafeiriou, Diletta Bianchini, Robert W. Chandler, Pasquale Rescigno, Wei Yuan, Suzanne Carreira, Maialen Barrero, Antonella Petremolo, Susana Miranda, Ruth Riisnaes, Daniel Nava Rodrigues, Bora Gürel, Semini Sumanasuriya, Alec Paschalis, Adam Sharp, Joaquı́n Mateo, Nina Tunariu, Arul M. Chinnaiyan, Colin C. Pritchard, Kevin Kelly, Johann S. de Bono

    Publicado 2018
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  15. 15
    Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer

    Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer por Alec Paschalis, Beshara Sheehan, Ruth Riisnaes, Daniel Nava Rodrigues, Bora Gürel, Cláudia Bertan, Ana Ferreira, Maryou B. Lambros, George Seed, Wei Yuan, David Dolling, Jon Welti, Antje Neeb, Semini Sumanasuriya, Pasquale Rescigno, Diletta Bianchini, Nina Tunariu, Suzanne Carreira, Adam Sharp, Wim J.G. Oyen, Johann S. de Bono

    Publicado 2019
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  16. 16
    Plasma <i>AR</i> and abiraterone-resistant prostate cancer

    Plasma <i>AR</i> and abiraterone-resistant prostate cancer por Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, Anuradha Jayaram, Nicola Casiraghi, Daniel Wetterskog, Samanta Salvi, Dino Amadori, Zafeiris Zafeiriou, Pasquale Rescigno, Diletta Bianchini, Giorgia Gurioli, Valentina Casadio, Suzanne Carreira, Jane Goodall, Anna Wingate, Roberta Ferraldeschi, Nina Tunariu, Penny Flohr, Ugo De Giorgi, Johann S. de Bono, Francesca Demichelis, Gerhardt Attard

    Publicado 2015
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  17. 17
    PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate

    PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate por Roberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, Susana Miranda, Ines Figueiredo, Pasquale Rescigno, Praful Ravi, Carmel Pezaro, Aurelius Omlin, David Lorente, Zafeiris Zafeiriou, Joaquı́n Mateo, Amelia Altavilla, Spyridon Sideris, Diletta Bianchini, Emily Grist, Khin Thway, Raquel Pérez-López, Nina Tunariu, Chris Parker, David P. Dearnaley, Alison Reid, Gerhardt Attard, Johann S. de Bono

    Publicado 2014
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  18. 18
    Characterizing CDK12-Mutated Prostate Cancers

    Characterizing CDK12-Mutated Prostate Cancers por Pasquale Rescigno, Bora Gürel, Rita Pereira, Mateus Crespo, Jan Rekowski, Mattia Rediti, Maialen Barrero, Joaquı́n Mateo, Diletta Bianchini, Carlo Messina, Maria D. Fenor de la Maza, Khobe Chandran, Juliet Carmichael, Christina Guo, Alec Paschalis, Adam Sharp, George Seed, Ines Figueiredo, Maryou Lambros, Susana Miranda, Ana Ferreira, Cláudia Bertan, Ruth Riisnaes, Núria Porta, Wei Yuan, Suzanne Carreira, Johann S. de Bono

    Publicado 2020
    Enlace del recurso
    Carta
    Agregar a favoritos
    Guardado en:
  19. 19
    Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial

    Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial por Suzanne Carreira, Núria Porta, Sara Arce‐Gallego, George Seed, Alba Llop‐Guevara, Diletta Bianchini, Pasquale Rescigno, Alec Paschalis, Cláudia Bertan, Chloe Baker, Jane Goodall, Susana Miranda, Ruth Riisnaes, Ines Figueiredo, Ana Ferreira, Rita Pereira, Mateus Crespo, Bora Gürel, Daniel Nava Rodrigues, Stephen J. Pettitt, Wei Yuan, Violeta Serra, Jan Rekowski, Christopher J. Lord, Emma Hall, Joaquı́n Mateo, Johann S. de Bono

    Publicado 2021
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  20. 20
    A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer

    A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer por Michael Paul Kolinsky, Pasquale Rescigno, Diletta Bianchini, Zafeiris Zafeiriou, Niven Mehra, Joaquı́n Mateo, Vasiliki Michalarea, Ruth Riisnaes, Mateus Crespo, I. Figueiredo, Susana Miranda, Daniel Nava Rodrigues, Penelope Flohr, Nina Tunariu, Udai Banerji, Ruth Ruddle, Adam Sharp, Jonathan Welti, Maryou Lambros, Suzanne Carreira, Florence I. Raynaud, Karen E. Swales, Stephen R. Plymate, Jun Luo, Holly Tovey, Núria Porta, Rachel M. Slade, Lorna Leonard, Emma Hall, Johann S. de Bono

    Publicado 2020
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: